Analysis of the key themes driving M&A activity reveals that artificial intelligence accounted for 7 medical devices deals announced in Q3 2022, worth a total value of $3.7m, according to GlobalData’s whitepaper on Artificial Intelligence in Medical Devices – M&A Deal Activity in Q3 2022. The $2.9m acquisition of Pilloxa by iZafe Group was the industry’s largest disclosed deal.
In value terms, artificial intelligence-related deal activity decreased by 82% in Q3 2022 compared with the previous quarter’s total of $20m and fell by 98% as compared to Q3 2021. Related deal volume increased by 133% in Q3 2022 versus the previous quarter and was 22% lower than in Q3 2021.
Target | Acquirer | Deal Value ($M) | Deal Date |
---|---|---|---|
Preventice | Boston Scientific | $1,225M | Jan-21 |
Decipher Biosciences | Veracyte | $600M | Feb-21 |
Modern Fertility | Roman Health Ventures | $225M | May-21 |
Inventive Healthcare Solutions; Virusight Diagnostic | $111M | Aug-21 | |
Vicarious Surgical | $102M | Apr-21 |
The top-ranked financial advisors supporting these M&A deals in 2022 were ARC Group; First Analysis Securities; Mangold Fondkommission with 1, 1, 1 deals respectively.
Advisor Name | 2022 Rank | 2021 Rank |
---|---|---|
ARC Group | 1 | - |
First Analysis Securities | 1 | - |
Mangold Fondkommission | 1 | - |
Turner Pope Investments (TPI) | 1 | - |
The top-ranked legal advisors supporting these M&A deals in 2022 were Bennett Jones; Bird & Bird; Nelson Mullins Riley & Scarborough with 1, 1, 1 deals respectively.
Advisor Name | 2022 Rank | 2021 Rank |
---|---|---|
Bennett Jones | 1 | - |
Bird & Bird | 1 | - |
Nelson Mullins Riley & Scarborough | 1 | - |
Rimon | 1 | - |
Wilson Sonsini Goodrich & Rosati Professional | 1 | 1 |
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.